New paradigms in oncological therapeutics: redefining combination chemotherapy
نویسندگان
چکیده
منابع مشابه
New paradigms in oncological therapeutics: redefining combination chemotherapy.
Definitions As oncological therapeutics evolve from cytotoxic-focused treatment to more mechanism-based interventions, it is time to redefine the terminology to more precisely reflect the tools being employed. Nuance counts; the widely used term for systemic cancer treatment with drugs, 'chemotherapy', carries with it well deserved negative connotations to the lay public. Among professionals, '...
متن کاملCombination therapeutics in complex diseases
The biological redundancies in molecular networks of complex diseases limit the efficacy of many single drug therapies. Combination therapeutics, as a common therapeutic method, involve pharmacological intervention using several drugs that interact with multiple targets in the molecular networks of diseases and may achieve better efficacy and/or less toxicity than monotherapy in practice. The d...
متن کاملChanging Paradigms in Breast Cancer Therapeutics: An Extended Abstract
These trials showed that invasive breast cancer has the ability to spread systemically very early, even before a cancer can be detected on mammographic imaging. Subsequently, clinical trial findings have shown that the use of postmastectomy radiation therapy improves survival in a subset of patients. Therefore, at least in some patients, better local (anatomic) control in addition to systemic t...
متن کاملTopotecan combination chemotherapy in two new rodent models of retinoblastoma.
Chemotherapy combined with laser therapy and cryotherapy has improved the ocular salvage rate for children with bilateral retinoblastoma. However, children with late-stage disease often experience recurrence shortly after treatment. To improve the vision salvage rate in advanced bilateral retinoblastoma, we have developed and characterized two new rodent models of retinoblastoma for screening c...
متن کاملSmall Molecule Therapeutics Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
Docetaxel chemotherapy remainsa standardof care formetastatic castration-resistant prostatecancer (CRPC). Docetaxelmodestly increases survival, yet results in frequent occurrence of side effects and resistant disease.An alternate chemotherapy with greater efficacy and minimal side effects is needed. Acquisition of metabolic aberrations promoting increased survival and metastasis in CRPC cells i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2002
ISSN: 0923-7534
DOI: 10.1093/annonc/mdf349